article thumbnail

FDA Guidance on Drug Advertising: Compliance Questions for Pharmaceutical Communications Professionals

ISEBOX

Oktavia has years of experience as a pharmaceutical communications professional, so she has a firm grasp on how to walk the narrow path of FDA regulatory compliance. This outcome is confusing – even for a seasoned pharmaceutical PR Exec like Oktavia. How could a little “like” trigger such a harsh response from the agency?

article thumbnail

How Pharmaceutical Marketing is Rewriting the Rule of Seven (One Potential Side Effect at a Time)

Stern + Associates

This “Rule of Seven” is being utterly obliterated, however, by pharmaceutical marketers. To illustrate, let’s dissect your average ad put out by any given pharmaceutical maker these days. The post How Pharmaceutical Marketing is Rewriting the Rule of Seven (One Potential Side Effect at a Time) appeared first on Stern + Associates.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Difference Between Health & Wellness

5W PR

It also includes pharmaceutical and medical device businesses. Stories can be shared through social media posts, blog articles and website testimonials. This could be blog articles, social media posts or videos that provide useful info on topics such as nutrition, exercise and mental health.

article thumbnail

When public expectations are unrealistic

The Stalwart Blog

I have been following the vaccine trial development that a lot of pharmaceutical companies are undertaking right now. In other words, consumers will think that the pharmaceutical companies are being ineffective in their development. There’s a lot of things to watch on the news of late. That’s not necessarily the case.

article thumbnail

Ethics and PR Do Mix, But It’s Up to PR to Tell That Story

PR News

With so many negative stories swirling around the health and pharmaceutical sector and 80% of people believing pharma puts profits ahead… Continued. The post Ethics and PR Do Mix, But It’s Up to PR to Tell That Story appeared first on PR News Blog.

Ethics 118
article thumbnail

The Anatomy of an FDA-Approved Tweet

ISEBOX

If you think that intentionally omitting this pertinent, valuable information is nothing more than a carefully constructed ploy to encourage you to come back and visit our blog…well, you’re exactly right. To comply with FDA regulations, your Tweet – and any other pharmaceutical PR content – must properly balance risks and benefits.

article thumbnail

How the FDA is Keeping Up with the Kardashians

ISEBOX

We’ve already talked about how pharmaceutical communications must equally balance risks and benefits in order to avoid being false or misleading. Anything that falls under the definition of “interactive promotional media” is content, including blogs, blog comments, website material and – yes – social media posts.